following an initial baseline period ( minimum , three months ) during which gentamicin use predominated , gentamicin and tobramycin were placed on restrictive control , establishing amikacin as the aminoglycoside of general use ( 86 percent of total aminoglycoside usage ) .
C0017436
gentamicin
C0002556
aminoglycoside